Cancer mortality in patients with psychiatric diagnoses: A higher hazard of cancer death does not lead to a higher cumulative risk of dying from cancer

Social Psychiatry and Psychiatric Epidemiology

Volumn 48, Issue 8, 2013, Pages 1289-1295

  Guan, Ng Chong ^a,b   Termorshuizen, Fabian ^b   Laan, Wijnand ^b   Smeets, Hugo M ^b   Zainal, Nor Zuraida ^a   Kahn, René S ^c   De Wit, Niek J ^b   Boks, Marco P M ^c  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Cancer; Competing risk; Mortality; Psychiatric diagnoses

Indexed keywords

ADULT; BIPOLAR DISORDER; CASE CONTROL STUDY; COMPLICATION; DEPRESSIVE DISORDER; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; NEOPLASM; NETHERLANDS; PROPORTIONAL HAZARDS MODEL; REGISTER; RETROSPECTIVE STUDY; RISK; RISK FACTOR; SCHIZOPHRENIA; SOCIOECONOMICS; TIME; ARTICLE; DEPRESSION;

ADULT; BIPOLAR DISORDER; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; NETHERLANDS; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SCHIZOPHRENIA; SOCIOECONOMIC FACTORS; TIME FACTORS;

EID: 84880837534     PISSN: 09337954     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00127-012-0612-8     Document Type: Article

References (39)

1. Commissioners in Lunacy for England and Wales (1909) Annual Report, HMSO, London
2. Mortensen PB (1989) The incidence of cancer in schizophrenic patients. J Epidemiol Commun Health 43:43-47
3. Goldacre MJ, Kurina LM, Wotton CJ, Yeates D, Seagroatt V (2005) Schizophrenia and cancer: an epidemiological study. Br J Psychiatry 187:334-338
4. Tran E, Rouillon F, Loze JY, Casadebaig F, Phillippe A, Vitry F, Limosin F (2009) Cancer mortality in patients with schizophrenia. Cancer 115:3555-3562
5. Hippisley-Cox J, Yinogradova Y, Coupland C, Parker C (2007) Risk of malignancy in patients with schizophrenia or bipolar disorder. Arch Gen Psychiatr 64:1368-1376
6. Saha S, Chant D, McGrath JA (2007) Systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry 64:1123-1131
7. Hodgson R, Wildgust HJ, Bushe CJ (2010) Cancer and schizophrenia: is there a paradox? J Psychopharmacol 24(11):51-60
8. Hawton K, Harriss L, Zahl D (2006) Deaths from all causes in a long-term follow-up study of 11 583 deliberate self-harm patients. Psych Med 36:397-405
9. Carney CP, Jones LS (2006) Medical comorbidity in women and men with bipolar disorders: a population-based controlled study. Psychosom Med 68:684-691
10. Barchana M, Levav I, Lipshitz I, Pugachova I, Kohn R, Wezman A, Grinshpoon A (2008) Enhanced cancer risk among patients with bipolar disorder. J Affect Disord 108:43-48
11. Oerlemans MEJ, van den Akker M, Schuurman AG, Kellen E, Buntinx F (2007) A meta-analysis on depression and subsequent cancer risk. Clin Pract Epidemiol Ment Health 3:29
12. Dalton SO, Mellemkjaer L, Olsen JH, Mortensen PB, Johansen C (2002) Depression and cancer risk: a register-based study of patients hospitalized with affective disorders, Denmark, 1969-1993. Am J Epidemiol 155(12):1088-1095
13. Putter H, Fiocco M, Geskus RB (2006) Tutorial in biostatistics: competing risks and multi-state models. Stat Med 7(26):2389-2430
14. Koller MT, Stijnen T, Steyerberg EW, Lubson J (2008) Meta-analyses of chronic disease trials with competing causes of death may yield biased odds ratio. J Clin Epidemiol 61(4):365-372
15. Smeets HM, Laan W, Engelhard IM, Boks MPM, Geerlings MI, de Wit NJ (2011) The psychiatric case register middle Netherlands. BMC Psychiatry 11:106
16. Laan W, Termorshuizen F, Smeets HM, Boks MP, de Wit NJ, Geerlings MI (2011) A comorbid anxiety disorder does not result in an excess risk of death among patients with a depressive disorder. J Affect Disord 135:284-291
17. Coviello V, Bogess M (2004) Cumulative incidence estimation in the presence of competing risks. STATA J 4:103-112
18. Chou FH, Tsai KY, Su CY, Lee CC (2011) The incidence and relative risk factors for developing cancer among patients with schizophrenia: a nine-year follow-up study. Schizophr Res 129(2-3):97-103
19. Cohen ME, Dembling B, Schorling JB (2002) The association between schizophrenia and cancer: a population-based mortality study. Schizophr Res 57:139-146
20. Høyer EH, Mortensen PB, Olesen AV (2000) Mortality and causes of death in a total national sample of patients with affective disorders admitted for the first time between 1973 and 1993. Br J Psychiatry 176:76-82
21. Joukamaa M, Heliövaara M, Knekt P, Aromaa A, Raitasalo R, Lehtinen V (2001) Mental disorders and cause-specific mortality. Br J Psychiatry 179:498-502
22. Gross AL, Gallo JJ, Eaton WW (2010) Depression and cancer risk: 24 years of follow-up of the Baltimore Epidemiologic Catchment Area sample. Cancer Causes Control 21(2):191-199
23. Brown S, Birtwistle J, Roe L, Thompson C (1999) The unhealthy lifestyle of people with schizophrenia. Psychol Med 29:697-701
24. Miech RA, Caspi A, Moffitt TE, Entner Wright BR, Silva PA (1999) Low socioeconomic status and mental disorders: a longitudinal study of selection and causation during young adulthood. AJS 104(4):1096-1131
25. Bebbington P, Ramana R (1995) The epidemiology of bipolar affective disorder. Soc Psychiatry Psychiatr Epidemiol 30:279-292
26. Tsuchiya KJ, Agerbo E, Byrne M, Mortensen PB (2004) Higher socio-economic status of parents may increase risk for bipolar disorder in the offspring. Psychol Med 34:787-793
27. Meyer JM, Stahl SM (2009) The metabolic syndrome and schizophrenia. Acta Psychiatr Scand 119:4-14
28. Steingart A, Cotterchio M, Kreiger N, Sloan M (2003) Antidepressant medication use and breast cancer risk: a case-control study. Int J Epidemiol 32:961-966
29. Coogan PF, Palmer JR, Strom BL, Rosenberg L (2005) Use of selective serotonin reuptake inhibitors and the risk of breast cancer. Am J Epidemiol 162:835-838
30. Carrillo JA, Benitez J (1999) Are antipsychotic drugs potentially chemopreventive agents for cancer? Eur J Clin Pharmacol 55:487-488
31. Park JK, Lee HJ, Kim JW et al (2004) Difference in p53 gene polymorphisms between Korean schizophrenia and lung cancer patients. Schizophr Res 67:71-74
32. Mykletun A, Bjerkeset O, Dewey M, Prince M, Overland S, Stewart R (2007) Anxiety, depression, and cause-specific mortality: the HUNT study. Psychosom Med 69:323-331
33. Ji J, Sundquist K, Ning Y, Kendler KS, Sundquist J, Chen X (2012) Incidence of cancer in patients with schizophrenia and their first-degree relatives: a population-based study in Sweden. Schizophr Bull. doi: 10.1093/schbul/sbs065
34. Chou FH, Tsai KY, Su CY, Lee CC (2011) The incidence and relative risk factors for developing cancer among patients with schizophrenia: a nine-year follow-up study. Schizophr Res 129:97-103
35. Goldacre MJ, Wotton CJ, Yeates D, Seagroatt V, Flint J (2007) Cancer in people with depression or anxiety: record-linkage study. Soc Psychiatry Psychiatr Epidemiol 42:683-689
36. Mitchell AJ, Malone D, Doebbeling CC (2009) Quality of medical care for people with and without comorbid mental illness and substance misuse: systematic review of comparative studies. Br J Psychiatry 194:491-499
37. Polednak AP (2012) US regional differences in death rates from depression. Soc Psychiatry Psychiatr Epidemiol. doi: 10.1007/s00127-012-0503-z
38. Bostwick JM, Pancratz VS (2000) Affective disorders and suicide risk: a reexamination. Am J Psychiatry 157:1925-1932
39. Palmer BA, Pankratz VS, Bostwick JM (2005) The lifetime risk of suicide in schizophrenia: a reexamination. Arch Gen Psychiatry 62:247-253